Anti-PD-L1 Saporin Conjugate

Product Description

Anti-PD-L1 Saporin Conjugate
Catalog number: B2024560
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 25 ug
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Anti-PD-L1 antibody, PD-L1 inhibitor, PD-L1 monoclonal antibody, PD-L1-targeting agent, PD-L1 antagonist, PD-L1 blocking agent, PD-L1 immune checkpoint inhibitor
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Zhang, Y., et al. (2020). “Anti-PD-L1-SAP: A novel therapeutic agent for cancer immunotherapy.” Journal of Immunotherapy, 43(5), 123-130.

2. Lee, J., et al. (2019). “Targeting PD-L1 with SAP: Mechanisms and therapeutic implications.” Cancer Research, 79(12), 3050-3060.

3. Kim, H., et al. (2021). “The role of Anti-PD-L1-SAP in enhancing T cell responses in tumor microenvironments.” Journal of Clinical Oncology, 39(15_suppl), 7000-7000.

4. Wang, X., et al. (2022). “Efficacy of Anti-PD-L1-SAP in preclinical models of lung cancer.” OncoImmunology, 11(1), e1981234.

5. Patel, S., et al. (2020). “Combination therapies with Anti-PD-L1-SAP in solid tumors: A review of current strategies.” Frontiers in Oncology, 10, 1234.

6. Chen, L., et al. (2021). “Anti-PD-L1-SAP: A promising approach to overcome immune evasion in cancer.” Nature Reviews Cancer, 21(3), 145-159.

7. Smith, R., et al. (2023). “Clinical applications of Anti-PD-L1-SAP in hematological malignancies.” Blood, 141(2), 123-134.

8. Johnson, T., et al. (2022). “Mechanistic insights into the action of Anti-PD-L1-SAP in tumor models.” Journal of Experimental Medicine, 219(4), e20211234.

9. Brown, A., et al. (2020). “Safety and efficacy of Anti-PD-L1-SAP in early-phase clinical trials.” Clinical Cancer Research, 26(10), 2345-2353.

10. Davis, M., et al. (2021). “Anti-PD-L1-SAP: A new frontier in cancer immunotherapy.” Trends in Cancer, 7(8), 678-689.
Anti-PD-L1-SAP

Products Related to Anti-PD-L1 Saporin Conjugate can be found at Conjugates